Position in RDY
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$620,147
+$570,636 QoQ
Shares Held
44,776
+6533.5% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2020
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in RDY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026SIMPLEX TRADING, LLC holds $16,102,016 across 33 Drug Manufacturers - Specialty & Generic names. RDY ranks #5 (3.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
74,697 | $8,829,932 | |
| 2 | NBIX |
Neurocrine Biosciences Inc
|
7,144 | $941,150 | |
| 3 | PRGO |
PERRIGO Co plc
|
87,608 | $940,909 | |
| 4 | HROW |
Harrow, Inc.
|
19,608 | $691,378 | |
| 5 | RDY |
Dr Reddys Laboratories Ltd
This page
|
44,776 | $620,147 | |
| 6 | CRON |
Cronos Group Inc.
|
212,416 | $533,164 | |
| 7 | VTRS |
Viatris Inc
|
38,221 | $516,365 | |
| 8 | BCRX |
Biocryst Pharmaceuticals Inc
|
53,965 | $513,746 |
All Filings in RDY
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $620,147 | 44,776 | Shares | Sole | 2026-05-14 | |
| 2024-03-31 | $49,511 | 675 | Shares | Sole | 2024-04-25 | |
| 2023-12-31 | $18,647 | 268 | Shares | Sole | 2024-02-02 | |
| 2023-09-30 | $22,602 | 338 | Shares | Sole | 2023-11-01 | |
| 2022-09-30 | $261 | 5 | Shares | Sole | 2022-11-04 | |
| 2020-09-30 | $12,033 | 173 | Shares | Sole | 2020-10-14 | |
| 2020-06-30 | $17,864 | 337 | Shares | Sole | 2020-07-13 | |
| No filing history on record for this holder in this stock. | ||||||